China’s WuXi to Sell Advanced Therapies Unit Amid US Restrictions
In a strategic move amidst growing regulatory pressures, WuXi AppTec, one of China’s leading biopharmaceutical companies, has announced its decision to sell its Advanced Therapies Unit. The sale comes in…
